carbostyril has been researched along with Diabetic Feet in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Donou, A; Kalantzi, S; Konsta, E; Loupa, CV; Meimeti, E; Voyatzoglou, ED | 1 |
Poole, RM | 1 |
Bhadada, SK; Bhansali, A; Dutta, P; Hajela, A; Mukherjee, S; Rastogi, A; Sukumar, S | 1 |
Fondelli, S; Iacopi, E; Leonildi, A; Menichetti, F; Piaggesi, A; Rizzo, L; Tagliaferri, E; Tascini, C; Tedeschi, A | 1 |
1 review(s) available for carbostyril and Diabetic Feet
Article | Year |
---|---|
Nemonoxacin: first global approval.
Topics: Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Drug Approval; Humans; Pneumonia; Quinolones | 2014 |
3 other study(ies) available for carbostyril and Diabetic Feet
Article | Year |
---|---|
Photosensitivity During Quinolone Therapy in Diabetic Foot Patients May Falsely Indicate Treatment Failure.
Topics: Aged; Clindamycin; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Male; Middle Aged; Osteomyelitis; Quinolones; Treatment Failure; Ulcer | 2023 |
The microbiology of diabetic foot infections in patients recently treated with antibiotic therapy: A prospective study from India.
Topics: Acinetobacter; Aged; Anti-Bacterial Agents; Cohort Studies; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Quinolones; Wound Infection | 2017 |
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.
Topics: Anti-Infective Agents; Candida; Diabetic Foot; Doxycycline; Enterococcus; Enterococcus faecalis; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Rifampin; Staphylococcus aureus; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2011 |